EQT
54
-3
NEE
54
4
AEE
60
-3
EMC
59
6
FOXA
52
-7
WHR
70
6
HAS
37
4
CFG
68
-2
ESS
67
3
ISRG
71
-3
MU
42
6
MMC
65
3
JNPR
50
4
KSS
46
12
GT
65
3
ROK
66
4
AAL
57
3
PSX
49
2
FOX
48
-3
UPS
64
4
EQT
54
-3
NEE
54
4
AEE
60
-3
EMC
59
6
FOXA
52
-7
WHR
70
6
HAS
37
4
CFG
68
-2
ESS
67
3
ISRG
71
-3
MU
42
6
MMC
65
3
JNPR
50
4
KSS
46
12
GT
65
3
ROK
66
4
AAL
57
3
PSX
49
2
FOX
48
-3
UPS
64
4
Financhill
Back

Replimune Group 10K Form

Sell
47

REPL
Replimune Group

Last Price:
14.40
Seasonality Move:
-14.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive REPL News And Ratings

See the #1 stock for the next 7 days that we like better than REPL

REPL Financial Statistics

Sales & Book Value

Annual Sales: $4.95K
Cash Flow: $-40.72M
Price / Cash Flow: 0
Annual Sales: $5.58
Price / Book: 2.38

Profitability

EPS (TTM): -3.05000
Net Income (TTM): $-213.02M
Gross Margin: $4.95K
Return on Equity: 0%
Return on Assets: 0%

Replimune Group Earnings Forecast

Key Replimune Group Financial Ratios

  • The Gross Profit Margin over the past 1 years for REPL is 100.00%.
  • The Selling, General & Administrative Expenses for REPL have been equal to 1,021,272.73% of Gross Profit Margin.
  • The Interest Expense is -3.09% of Operating Income.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Replimune Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: REPL
CUSIP: 76029N
Website: replimune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

REPL Technical Analysis vs Fundamental Analysis

Sell
47
Replimune Group (REPL) is a Sell

Is Replimune Group a Buy or a Sell?

  • Replimune Group stock is rated a Sell
    The current Replimune Group [REPL] share price is $13.26. The Score for REPL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.